The US medical research agency plans to offer funding over five years through a newly launched consortium, expected to include 30 sites across the country.
Genomics England has selected CRO Icon to manage data for what it says is the largest genome sequencing project of its kind for cancer and rare diseases.
The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s disease, lupus and rheumatoid arthritis.
GATC Biotech has expanded its human genome sequencing services and, having performed a pilot study, is “amazed” by the potential the techniques have for cancer research and diagnostics.
Invitrogen plans to cement its place as one of the world's largest
suppliers of analysis tools and reagents for the life science and
pharmaceutical industries by acquiring Applied Biosystems (ABI).
Invitrogen has formed a collaboration to supply reagents for
Solexa's Genome Analysis System, a sequencing technology that has
the potential to generate over a billion bases of DNA sequence data
per run.
According to a recent report, analytic separation technology will
continue to evolve as limitations are addressed and standards grow
even more rigorous, as market drivers such as quality control,
instrument design, and software in...
A grant totalling more than $32 million to advance the development
of innovative sequencing lab technologies to reduce the cost of DNA
sequencing and expand the use of genomics in biomedical research
has been awarded by The National...
According to a report, it takes 7-10 years to develop and market a
drug with costs exceeding $800 million (€625 million). This
revelation is set to add to the pressure already facing
pharmaceutical and biotechnology companies which...
Celera Diagnostics announced it has entered into a collaboration
with Merck to identify novel targets for drug discovery and
diagnostic markers related to Alzheimer's disease.
The first grants have been awarded in the ENCODE program,an
extension of the Human Genome Project which is hoping to develop an
encyclopedia of function for all the sequences in the human genetic
map. A $35m pilot project aimed at...
Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Research (TIGR).
Researchers have now completed the sequencing of the human genome,
to an accuracy of 99.999 per cent, nearly three years after the
first 'working' draft was published to great fanfare in June 2000.
The achievement comes...
